Quantcast

Latest Ribavirin Stories

2011-09-19 05:25:41

(Ivanhoe Newswire)--- According to the CDC, Hepatitis C is the most common chronic blood borne infection in the United States affecting more than 3.2 million people.  But, a new drug has been found to significantly increase the cure rates for those infected. Hepatitis C virus (HCV) is a disease that can cause severe liver damage, joint pain and even damage to the nervous system and brain. HCV genotype 1 is the most common form of the virus and also the most difficult to treat. ...

2011-09-15 12:18:57

Response-guided treatment with drug telaprevir can be shortened to 6 months for many, says research published in New England Journal of Medicine Treatment with a telaprevir-based combination regimen for hepatitis C — heretofore a chronic, destructive and difficult to manage disease — effectively can be shortened to six months in about two-thirds of patients, finds a new study published Thursday in the New England Journal of Medicine. Telaprevir, a drug approved for use...

2011-09-15 11:35:54

University of Cincinnati research published in the Sept. 14, 2011, advance online edition of the New England Journal of Medicine shows that patients with hepatitis C who took a combination medication–a telaprevir-based regimen that is commonly used to treat the illness–for 24 weeks were cured. Usually, the treatment is administered for 48 weeks, and these results show that extended treatment is unnecessary, possibly changing the standard of care for hepatitis C patients....

2011-09-15 11:34:05

A new multinational study finds that a 24-week treatment course for hepatitis C that adds telaprevir to peginterferon alfa and ribavirin is just as effective as a 48-week regimen for many patients. This is good news for up to 4 million people in the U.S. who suffer from this chronic liver disease, many of whom will undergo treatment for hepatitis C, said Michael W. Fried, MD, professor of medicine at the University of North Carolina at Chapel Hill, director of the UNC Liver Center and a...

2011-09-14 11:15:38

Press release from PLoS Medicine In this week's PLoS Medicine, David Booth of the University of Sydney, Australia and colleagues show that genotyping hepatitis C patients for the IL28B, HLA-C and KIR genes substantially improves doctors' ability to predict whether or not patients will respond to antiviral treatment. The results of the study suggest that an interaction between IL28B, HLA-C and KIRs provides a mechanism for hepatitis C viral control and highlight new insights into how the...

2011-09-14 05:29:43

(Ivanhoe Newswire) — Genotyping hepatitis C patients significantly improves doctors´ ability to predict whether or not patients will respond to antiviral treatment. The results of the study suggest that an interaction between IL28B, HLA-C and KIRs genes provides a mechanism for hepatitis C viral control and highlight new insights into how the drug combination of pegylated interferon alpha and ribavirin clears hepatitis C virus infections, findings that may lead to improved...


Latest Ribavirin Reference Libraries

0_b3d737125981cbedce0bb0c8511e6b65
2011-02-17 15:14:03

Lassa fever, first described in 1969 in Lassa, is an acute viral hemorrhagic fever. Clinical cases were known a decade before this but were not associated with this viral pathogen. It is endemic in West African countries and causes approximately 5,000 deaths. The Natal Multimammate Mouse is the primary animal host. The rodent is a source of protein but the virus is usually transmitted by the contact with the feces and urine of animals accessing grain stores in residences. The lassa virus...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related